Semen Washing and Intrauterine Insemination for Reducing the Risk of Human Immunodeficiency Virus Transmission in Serodiscordant Couples: A Cross-sectional Study

Overview

Journal J Hum Reprod Sci

Date 2024 Aug 2

PMID 39091439

Authors

Duru Shah

Raj Harjani

Vishesha Yadav

Affiliations

Soon will be listed here.

Abstract

Background: Antiretroviral therapy has helped human immunodeficiency virus (HIV)-infected people live an enhanced quality of life and attempt for a pregnancy, without placing their partner at risk. Although periconceptional pre-exposure prophylaxis for the uninfected partner and consistent antiretroviral therapy for the HIV-infected partner are important to prevent HIV transmission, semen washing could be a great option to further reduce the semen viral load.

Aim: The aim of this study were as follows: to determine if semen washing with intrauterine insemination provides an added safety net to HIV-serodiscordant couples when the male partner is HIV-infected and virally suppressed and to determine if the U = U concept (undetectable = untransmittable) holds true in virally suppressed HIV-infected males.

Settings And Design: This was an observational study conducted in seropositive HIV men under treatment with highly active antiretroviral therapy (HAART) in collaboration with Metropolis Laboratory, a CAP recognised private Healthcare Laboratory in Mumbai, India.

Materials And Methods: Blood and semen samples were collected from a total of 110 adult HIV-1-infected males virally suppressed on HAART. These samples were processed to assess the viral load in plasma as well as raw and processed semen fractions.

Statistical Analysis Used: Descriptive statistics were used to analyse the data.

Results: Only men with plasma viral loads < 1000 copies were selected in our study. Out of the 110 HIV-infected individuals, 102 (92.73%) patients had undetectable (<20 copies/ml) plasma viral load while 8 (7.27%) patients had a detectable (>20 copies/ml) viral load, who were excluded from the study. In the virally suppressed 102 men, the raw semen samples of 100 men showed an undetectable viral load, while 2 samples showed detectable contamination, even though their plasma samples from the blood showed a viral load of <20 copies/ml. The semen was then separated into the sperm and the seminal plasma samples. The seminal plasma had <20 copies/ml in 95 samples (93.14%) but a detectable viral load in 7 (6.86%) samples. After subjecting all the 102 processed (post-wash) sperm samples to quantitative analysis, an undetectable viral load of <20 copies/ml was found in all the samples. Thus, the raw sample (prewashed),seminal plasma and processed (postwash) samples were evaluated. The post-wash sperm sample showing zero contamination was frozen for intrauterine insemination (IUI) in the uninfected female partner.

Conclusions: Semen washing with IUI should be advocated as a safe, efficacious way to increase the safety net and to further reduce the minimal risk of HIV transmission in serodiscordant couples in addition to the U = U concept.

References

Barnes A, Riche D, Mena L, Sison T, Barry L, Reddy R . Efficacy and safety of intrauterine insemination and assisted reproductive technology in populations serodiscordant for human immunodeficiency virus: a systematic review and meta-analysis. Fertil Steril. 2014; 102(2):424-34. DOI: 10.1016/j.fertnstert.2014.05.001. View

Ford O, Rufurwadzo T, Richman B, Green I, Alesi J . Adopting U = U to end stigma and discrimination. J Int AIDS Soc. 2022; 25(3):e25891. PMC: 8886179. DOI: 10.1002/jia2.25891. View

Eisinger R, Dieffenbach C, Fauci A . HIV Viral Load and Transmissibility of HIV Infection: Undetectable Equals Untransmittable. JAMA. 2019; 321(5):451-452. DOI: 10.1001/jama.2018.21167. View

Frapsauce C, Grabar S, Leruez-Ville M, Launay O, Sogni P, Gayet V . Impaired sperm motility in HIV-infected men: an unexpected adverse effect of efavirenz?. Hum Reprod. 2015; 30(8):1797-806. DOI: 10.1093/humrep/dev141. View

Leech A, Bortoletto P, Christiansen C, Drainoni M, Linas B, Roeca C . Assessing access to assisted reproductive services for serodiscordant couples with human immunodeficiency virus infection. Fertil Steril. 2018; 109(3):473-477. PMC: 9720783. DOI: 10.1016/j.fertnstert.2017.11.039. View

Jeronimo A, Baza M, Rio I, Vera M, Hernando V, Castilla J . Factors associated with seminal impairment in HIV-infected men under antiretroviral therapy. Hum Reprod. 2016; 32(2):265-271. DOI: 10.1093/humrep/dew321. View

Kariuki S, Selhorst P, Norman J, Cohen K, Rebe K, Williamson C . Detectable HIV-1 in semen in individuals with very low blood viral loads. Virol J. 2020; 17(1):29. PMC: 7059658. DOI: 10.1186/s12985-020-01300-6. View

Politch J, Mayer K, Anderson D . Depletion of CD4+ T cells in semen during HIV infection and their restoration following antiretroviral therapy. J Acquir Immune Defic Syndr. 2009; 50(3):283-9. PMC: 2680744. DOI: 10.1097/QAI.0b013e3181989870. View

Balasubramaniam M, Pandhare J, Dash C . Immune Control of HIV. J Life Sci (Westlake Village). 2019; 1(1):4-37. PMC: 6714987. View

10.

Rodger A, Cambiano V, Bruun T, Vernazza P, Collins S, van Lunzen J . Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy. JAMA. 2016; 316(2):171-81. DOI: 10.1001/jama.2016.5148. View

11.

Pasquier C, Walschaerts M, Raymond S, Moinard N, Saune K, Daudin M . Patterns of residual HIV-1 RNA shedding in the seminal plasma of patients on effective antiretroviral therapy. Basic Clin Androl. 2017; 27:17. PMC: 5590187. DOI: 10.1186/s12610-017-0063-x. View

12.

Inoue O, Kuji N, Ito H, Yamada M, Hamatani T, Oyadomari A . Clinical efficacy of a combination of Percoll continuous density gradient and swim-up techniques for semen processing in HIV-1 serodiscordant couples. Asian J Androl. 2016; 19(2):208-213. PMC: 5312220. DOI: 10.4103/1008-682X.173442. View

13.

Lee B, Kjaerulf F, Turner S, Cohen L, Donnelly P, Muggah R . Transforming Our World: Implementing the 2030 Agenda Through Sustainable Development Goal Indicators. J Public Health Policy. 2016; 37 Suppl 1:13-31. DOI: 10.1057/s41271-016-0002-7. View

14.

Broyles L, Luo R, Boeras D, Vojnov L . The risk of sexual transmission of HIV in individuals with low-level HIV viraemia: a systematic review. Lancet. 2023; 402(10400):464-471. PMC: 10415671. DOI: 10.1016/S0140-6736(23)00877-2. View

15.

Kawwass J, Smith D, Kissin D, Haddad L, Boulet S, Sunderam S . Strategies for Preventing HIV Infection Among HIV-Uninfected Women Attempting Conception with HIV-Infected Men - United States. MMWR Morb Mortal Wkly Rep. 2017; 66(21):554-557. PMC: 5657819. DOI: 10.15585/mmwr.mm6621a2. View

16.

Kushnir V, Lewis W . Human immunodeficiency virus/acquired immunodeficiency syndrome and infertility: emerging problems in the era of highly active antiretrovirals. Fertil Steril. 2011; 96(3):546-53. PMC: 3165097. DOI: 10.1016/j.fertnstert.2011.05.094. View

17.

Zafer M, Horvath H, Mmeje O, van der Poel S, Semprini A, Rutherford G . Effectiveness of semen washing to prevent human immunodeficiency virus (HIV) transmission and assist pregnancy in HIV-discordant couples: a systematic review and meta-analysis. Fertil Steril. 2015; 105(3):645-655.e2. PMC: 4779710. DOI: 10.1016/j.fertnstert.2015.11.028. View

18.

Cohen M, Chen Y, McCauley M, Gamble T, Hosseinipour M, Kumarasamy N . Antiretroviral Therapy for the Prevention of HIV-1 Transmission. N Engl J Med. 2016; 375(9):830-9. PMC: 5049503. DOI: 10.1056/NEJMoa1600693. View

19.

Semprini A, Bozzo M, Ravizza M, Taglioretti A, Sulpizio P, Albani E . Insemination of HIV-negative women with processed semen of HIV-positive partners. Lancet. 1992; 340(8831):1317-9. DOI: 10.1016/0140-6736(92)92495-2. View

20.

Zamora M, Obradors A, Woodward B, Vernaeve V, Vassena R . Semen residual viral load and reproductive outcomes in HIV-infected men undergoing ICSI after extended semen preparation. Reprod Biomed Online. 2016; 32(6):584-90. DOI: 10.1016/j.rbmo.2016.02.014. View